Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Health-related quality of life with Oral Azacitidine (Oral-AZA) in patients with Acute Myeloid Leukemia (AML) in first remission following Intensive Chemotherapy (IC): Results from the phase 3 QUAZAR AML-001 maintenance trial
- Authors
- Martens, UM[Martens, U. M.]; Roboz, G[Roboz, G.]; Dohner, H[Doehner, H.]; Pocock, C[Pocock, C.]; Dombret, H[Dombret, H.]; Ravandi, F[Ravandi, F.]; Jang, JH[Jang, J. H.]; Selleslag, D[Selleslag, D.]; Mayer, J[Mayer, J.]; Liesveld, J[Liesveld, J.]; Bernal, T[Bernal, T.]; La Torre, I[La Torre, I]; Skikne, B[Skikne, B.]; Braverman, J[Braverman, J.]; Nehme, SA[Nehme, Abi S.]; Beach, C[Beach, C.]; Wei, A[Wei, A.]
- Issue Date
- Sep-2021
- Publisher
- KARGER
- Citation
- ONCOLOGY RESEARCH AND TREATMENT, v.44, pp.112 - 113
- Indexed
- SCIE
SCOPUS
- Journal Title
- ONCOLOGY RESEARCH AND TREATMENT
- Volume
- 44
- Start Page
- 112
- End Page
- 113
- ISSN
- 2296-5270
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.